Feed aggregator

Cancer Patients Want Warp Speed Given to Oncology Research Next

Biospace news - Tue, 08/31/2021 - 02:00
While the speed of science is both lauded and mistrusted by near-equal parts of the population, the over 22 million Americans with cancer are now saying, “Wait, what about us?”

Renovacor’s Marc Semigran Transitioned to Industry to Put Patients First

Biospace news - Tue, 08/31/2021 - 02:00
The burgeoning genetic capabilities were instrumental in causing Semigran to transition into the biotech industry.

Outgoing Moderna CMO Lands Seat on Teva Pharmaceuticals Board of Directors

Biospace news - Tue, 08/31/2021 - 02:00
Teva announced the appointment in a filing with the U.S. Securities and Exchange Commission. Zaks will serve on the board’s Science and Technology Committee.

Departure of Founder and CEO Heightens Uncertainty for Galapagos

Biospace news - Tue, 08/31/2021 - 02:00
As CEO, Stolpe has presided over some highs with the launch of JAK1 inhibitor Jyseleca (filgotinib) in Europe, as well as the devaluation of the company's share price by 70%.

Korean Pharma's Phase III COVID Trial Will Compare Candidate to AZ Vaccine

Biospace news - Tue, 08/31/2021 - 02:00
​The trial will enroll about 4,000 people worldwide to confirm the drug's safety and immunogenicity profiles.

Mixed Bag in Phase II Alzheimer's Trial

Biospace news - Tue, 08/31/2021 - 02:00
AC Immune and Genentech announced that their Phase II Lauriet trial of semorinemab in mild-to-moderate Alzheimer’s disease hit one of its co-primary endpoints.

Umoja’s New Manufacturing Facility Highlights Colorado's Biopharma Potential

Biospace news - Mon, 08/30/2021 - 02:00
The state-of-the-art 146,000 square foot facility will make it easier for Umoja to eliminate crucial CAR-T production barriers.

Early CureVac mRNA Work Points to Therapeutic Promise in Liver Fibrosis

Biospace news - Mon, 08/30/2021 - 02:00
The research underlines the progress being made in messenger RNA approaches, as spotlighted by the success of the mRNA vaccines against COVID-19.

SpringWorks Teams with Dana-Farber Institute on Potential Cancer Therapy

Biospace news - Mon, 08/30/2021 - 02:00
​SpringWorks has announced a research collaboration with the Dana-Farber Cancer Institute to advance its therapy development efforts for multiple myeloma and related diseases.

JHL Co-founders Convicted of Trade Secret Theft

Biospace news - Mon, 08/30/2021 - 02:00
Two former executives of JHL Biotech were indicted on charges of orchestrating the theft of trade secrets, wire fraud exceeding $101 million, and money laundering.

Endless RNA Creator Secures $440 Million to Build Gigabase Factory

Biospace news - Mon, 08/30/2021 - 02:00
​Laronde has managed to secure as much as $440 million from a Series B financing round to support as many as 100 Endless RNA (eRNA) products and drug programs over the next decade.

Regeneron and Sanofi Monopoly on Atopic Dermatitis Market May Soon End

Biospace news - Mon, 08/30/2021 - 02:00
Regeneron and Sanofi broke ground with the 2017 approval of the first biologic drug for atopic dermatitis, the most common form of eczema driven by allergic reactions.

Bone Therapeutics Breaks After Phase III Osteoarthritis Failure

Biospace news - Mon, 08/30/2021 - 02:00
Shares of Bone Therapeutics are down more than 34% on the Euronext stock exchange after the company announced its Phase III osteoarthritis study failed to meet primary and critical secondary endpoints.

New COVID-19 Variant C.1.2 Sparking International Concern

Biospace news - Mon, 08/30/2021 - 02:00
A new variant, C.1.2. is causing public health experts worldwide to keep an eye out for its presence as it seems to be more infectious and even more resistant to vaccines than other variants.

Revelation Biosciences Merges with SPAC Company to List on Nasdaq

Biospace news - Mon, 08/30/2021 - 02:00
The SPAC craze continues as San Diego-based Revelation Biosciences announced its merger with Petra Acquisition that will result in the company’s listing on the Nasdaq exchange.

Clinical Catch-Up: August 23-27

Biospace news - Mon, 08/30/2021 - 02:00
It was a busy week for clinical trial news. Here’s a look.